Skip to main content
Erschienen in: Heart and Vessels 3/2021

29.09.2020 | Original Article

Vasospastic angina and overlapping cardiac disorders in patients resuscitated from cardiac arrest

verfasst von: Kazuya Tateishi, Yuichi Saito, Hideki Kitahara, Hiroyuki Takaoka, Yusuke Kondo, Takashi Nakayama, Yoshihide Fujimoto, Yoshio Kobayashi

Erschienen in: Heart and Vessels | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

Vasospastic angina (VSA) reportedly accounts for one form of sudden cardiac arrest (SCA). Intracoronary acetylcholine (ACh) testing is useful for diagnosing VSA although invasive provocation testing after SCA is a clinical challenge. In addition, even if the ACh test is positive, any causal relationship between VSA and SCA is often unclear because patients with VSA may have other underlying cardiac disorders.

Methods

A total of 20 patients without overt structural heart disease who had been fully resuscitated from SCA were included. All patients underwent the ACh provocation test and scrutiny such as cardiac computed tomography or magnetic resonance imaging. Patients were followed up for all-cause death or recurrent SCA including appropriate implantable cardioverter defibrillator therapy.

Results

An ACh provocation test was performed 20 ± 17 days after cardiac arrest. Fifteen out of 20 (75.0%) patients had a positive ACh test and 2 (10.0%) had adverse events such as ventricular tachycardia and transient cardiogenic shock during the test. In patients with a positive ACh test, 6 of 15 (40.0%) patients had other overlapping cardiac disorders such as long QT syndrome, Brugada syndrome, cardiac sarcoidosis, myocarditis, or cardiomyopathy. Long-term prognosis was not different regardless of a positive ACh test or the presence of other cardiac disorders overlapping with VSA.

Conclusions

Three-quarters of the patients who had been resuscitated from SCA had a positive ACh test. Further examinations revealed other overlapping cardiac disorders in addition to VSA in 40% of patients with a positive ACh test.
Literatur
1.
Zurück zum Zitat Ong P, Aziz A, Hansen HS, Prescott E, Athanasiadis A, Sechtem U (2015) Structural and functional coronary artery abnormalities in patients with vasospastic angina pectoris. Circ J 79:1431–1438CrossRef Ong P, Aziz A, Hansen HS, Prescott E, Athanasiadis A, Sechtem U (2015) Structural and functional coronary artery abnormalities in patients with vasospastic angina pectoris. Circ J 79:1431–1438CrossRef
2.
Zurück zum Zitat Yasue H, Takizawa A, Nagao M, Nishida S, Horie M, Kubota J, Omote S, Takaoka K, Okumura K (1988) Long-term prognosis for patients with variant angina and influential factors. Circulation 78:1–9CrossRef Yasue H, Takizawa A, Nagao M, Nishida S, Horie M, Kubota J, Omote S, Takaoka K, Okumura K (1988) Long-term prognosis for patients with variant angina and influential factors. Circulation 78:1–9CrossRef
3.
Zurück zum Zitat Myerburg RJ, Kessler KM, Mallon SM, Cox MM, deMarchena E, Interian A Jr, Castellanoset A (1992) Life-threatening ventricular arrhythmias in patients with silent myocardial ischemia due to coronary artery spasm. N Engl J Med 326:1451–1455CrossRef Myerburg RJ, Kessler KM, Mallon SM, Cox MM, deMarchena E, Interian A Jr, Castellanoset A (1992) Life-threatening ventricular arrhythmias in patients with silent myocardial ischemia due to coronary artery spasm. N Engl J Med 326:1451–1455CrossRef
4.
Zurück zum Zitat Chevalier P, Dacosta A, Defaye P, Chalvidan T, Bonnefoy E, Kirkorian G, Isaaz K, Denis B, Touboulet P (1998) Arrhythmic cardiac arrest due to isolated coronary artery spasm: long-term outcome of seven resuscitated patients. J Am Coll Cardiol 31:57–61CrossRef Chevalier P, Dacosta A, Defaye P, Chalvidan T, Bonnefoy E, Kirkorian G, Isaaz K, Denis B, Touboulet P (1998) Arrhythmic cardiac arrest due to isolated coronary artery spasm: long-term outcome of seven resuscitated patients. J Am Coll Cardiol 31:57–61CrossRef
5.
Zurück zum Zitat Meune C, Joly LM, Chiche JD, Charpentier J, Leenhardt A, Rozenberg A, Carli P, Sauval P, Weber S, Cracan A, Spauldinget C (2003) Diagnosis and management of out-of-hospital cardiac arrest secondary to coronary artery spasm. Resuscitation 58:145–152CrossRef Meune C, Joly LM, Chiche JD, Charpentier J, Leenhardt A, Rozenberg A, Carli P, Sauval P, Weber S, Cracan A, Spauldinget C (2003) Diagnosis and management of out-of-hospital cardiac arrest secondary to coronary artery spasm. Resuscitation 58:145–152CrossRef
6.
Zurück zum Zitat Kobayashi N, Hata N, Shimura T, Yokoyama S, Shirakabe A, Shinada T, Tomita K, Murakami D, Takano M, Seino Y, Matsumoto H, Mashiko K, Mizuno K (2013) Characteristics of patients with cardiac arrest caused by coronary vasospasm. Circ J 77:673–678CrossRef Kobayashi N, Hata N, Shimura T, Yokoyama S, Shirakabe A, Shinada T, Tomita K, Murakami D, Takano M, Seino Y, Matsumoto H, Mashiko K, Mizuno K (2013) Characteristics of patients with cardiac arrest caused by coronary vasospasm. Circ J 77:673–678CrossRef
7.
Zurück zum Zitat Tateishi K, Abe D, Iwama T, Hamabe Y, Aonuma K, Sato A (2018) Clinical value of ST-segment change after return of spontaneous cardiac arrest and emergent coronary angiography in patients with out-of-hospital cardiac arrest: diagnostic and therapeutic importance of vasospastic angina. Eur Heart J Acute Cardiovasc Care 7:405–413CrossRef Tateishi K, Abe D, Iwama T, Hamabe Y, Aonuma K, Sato A (2018) Clinical value of ST-segment change after return of spontaneous cardiac arrest and emergent coronary angiography in patients with out-of-hospital cardiac arrest: diagnostic and therapeutic importance of vasospastic angina. Eur Heart J Acute Cardiovasc Care 7:405–413CrossRef
8.
Zurück zum Zitat Komatsu M, Takahashi J, Fukuda K, Takagi Y, Shiroto T, Nakano M, Kondo M, Tsuburaya R, Hao K, Nishimiya K, Nihei T, Matsumoto Y, Ito K, Sakata Y, Miyata S, Shimokawa H (2016) Usefulness of testing for coronary artery spasm and programmed ventricular stimulation in survivors of out-of-hospital cardiac arrest. Circ Arrhythm Electrophysiol 9:e003798CrossRef Komatsu M, Takahashi J, Fukuda K, Takagi Y, Shiroto T, Nakano M, Kondo M, Tsuburaya R, Hao K, Nishimiya K, Nihei T, Matsumoto Y, Ito K, Sakata Y, Miyata S, Shimokawa H (2016) Usefulness of testing for coronary artery spasm and programmed ventricular stimulation in survivors of out-of-hospital cardiac arrest. Circ Arrhythm Electrophysiol 9:e003798CrossRef
9.
Zurück zum Zitat Beltrame JF, Crea F, Kaski JC, Ogawa H, Ong P, Sechtem U, Shimokawa H, Bairey Merz CN, Coronary Vasomotion Disorders International Study Group (COVADIS) (2017) International standardization of diagnostic criteria for vasospastic angina. Eur Heart J 38:2565–2568PubMed Beltrame JF, Crea F, Kaski JC, Ogawa H, Ong P, Sechtem U, Shimokawa H, Bairey Merz CN, Coronary Vasomotion Disorders International Study Group (COVADIS) (2017) International standardization of diagnostic criteria for vasospastic angina. Eur Heart J 38:2565–2568PubMed
10.
Zurück zum Zitat Waldmann V, Bougouin W, Karam N, Dumas F, Sharifzadehgan A, Gandjbakhch E, Algalarrondo V, Narayanan K, Zhao A, Amet D, Jost D, Geri G, Lamhaut L, Beganton F, Ludes B, Bruneval P, Plu I, Hidden-Lucet F, Albuisson J, Lavergne T, Piot O, Alonso C, Leenhardt A, Lellouche N, Extramiana F, Cariou A, Jouven X, Marijon E, Paris-SDEC investigators (2018) Characteristics and clinical assessment of unexplained sudden cardiac arrest in the real-world setting: focus on idiopathic ventricular fibrillation. Eur Heart J 39:1981–1987CrossRef Waldmann V, Bougouin W, Karam N, Dumas F, Sharifzadehgan A, Gandjbakhch E, Algalarrondo V, Narayanan K, Zhao A, Amet D, Jost D, Geri G, Lamhaut L, Beganton F, Ludes B, Bruneval P, Plu I, Hidden-Lucet F, Albuisson J, Lavergne T, Piot O, Alonso C, Leenhardt A, Lellouche N, Extramiana F, Cariou A, Jouven X, Marijon E, Paris-SDEC investigators (2018) Characteristics and clinical assessment of unexplained sudden cardiac arrest in the real-world setting: focus on idiopathic ventricular fibrillation. Eur Heart J 39:1981–1987CrossRef
11.
Zurück zum Zitat Kitamura T, Fukamizu S, Hojo R, Aoyama Y, Komiyama K, Nishizaki M, Sakurada H, Hiraoka M (2016) Early repolarization pattern and its day-to-day dynamic change as markers for ventricular fibrillation in patients with vasospastic angina. Europace 18:1252–1258CrossRef Kitamura T, Fukamizu S, Hojo R, Aoyama Y, Komiyama K, Nishizaki M, Sakurada H, Hiraoka M (2016) Early repolarization pattern and its day-to-day dynamic change as markers for ventricular fibrillation in patients with vasospastic angina. Europace 18:1252–1258CrossRef
12.
Zurück zum Zitat Shimizu W, Noda T, Takaki H, Kurita T, Nagaya N, Satomi K, Suyama K, Aihara N, Kamakura S, Sunagawa K, Echigo S, Nakamura K, Ohe T, Towbin JA, Napolitano C, Priori SG (2003) Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome. J Am Coll Cardiol 41:633–642CrossRef Shimizu W, Noda T, Takaki H, Kurita T, Nagaya N, Satomi K, Suyama K, Aihara N, Kamakura S, Sunagawa K, Echigo S, Nakamura K, Ohe T, Towbin JA, Napolitano C, Priori SG (2003) Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome. J Am Coll Cardiol 41:633–642CrossRef
13.
Zurück zum Zitat JCS Joint Working Group (2014) Guidelines for diagnosis and treatment of patients with vasospastic angina (coronary spastic angina) (JCS 2013). Circ J 78:2779–2801CrossRef JCS Joint Working Group (2014) Guidelines for diagnosis and treatment of patients with vasospastic angina (coronary spastic angina) (JCS 2013). Circ J 78:2779–2801CrossRef
14.
Zurück zum Zitat Saito Y, Kitahara H, Shoji T, Tokimasa S, Nakayama T, Sugimoto K, Fujimoto Y, Kobayashi Y (2017) Relation between severity of myocardial bridge and vasospasm. Int J Cardiol 248:34–38CrossRef Saito Y, Kitahara H, Shoji T, Tokimasa S, Nakayama T, Sugimoto K, Fujimoto Y, Kobayashi Y (2017) Relation between severity of myocardial bridge and vasospasm. Int J Cardiol 248:34–38CrossRef
15.
Zurück zum Zitat Tateishi K, Saito Y, Kitahara H, Shoji T, Kadohira T, Nakayama T, Fujimoto Y, Kobayashi Y (2018) Safety and usefulness of acetylcholine provocation test in patients with no culprit lesions on emergency coronary angiography. Int J Cardiol 269:27–30CrossRef Tateishi K, Saito Y, Kitahara H, Shoji T, Kadohira T, Nakayama T, Fujimoto Y, Kobayashi Y (2018) Safety and usefulness of acetylcholine provocation test in patients with no culprit lesions on emergency coronary angiography. Int J Cardiol 269:27–30CrossRef
16.
Zurück zum Zitat Saito Y, Kitahara H, Shoji T, Tokimasa S, Nakayama T, Sugimoto K, Fujimoto Y, Kobayashi Y (2018) Feasibility and safety of outpatient cardiac catheterization with intracoronary acetylcholine provocation test. Heart Vessels 33:846–852CrossRef Saito Y, Kitahara H, Shoji T, Tokimasa S, Nakayama T, Sugimoto K, Fujimoto Y, Kobayashi Y (2018) Feasibility and safety of outpatient cardiac catheterization with intracoronary acetylcholine provocation test. Heart Vessels 33:846–852CrossRef
18.
Zurück zum Zitat Takaoka H, Funabashi N, Ozawa K, Uehara M, Sano K, Komuro I, Kobayashi Y (2018) Improved diagnosis of detection of late enhancement in left ventricular myocardium using 2nd generation 320-Slice CT reconstructed with FIRST in non-ischemic cardiomyopathy. Int Heart J 59:542–549CrossRef Takaoka H, Funabashi N, Ozawa K, Uehara M, Sano K, Komuro I, Kobayashi Y (2018) Improved diagnosis of detection of late enhancement in left ventricular myocardium using 2nd generation 320-Slice CT reconstructed with FIRST in non-ischemic cardiomyopathy. Int Heart J 59:542–549CrossRef
19.
Zurück zum Zitat Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C, Blom N, Brugada J, Chiang CE, Huikuri H, Kannankeril P, Krahn A, Leenhardt A, Moss A, Schwartz PJ, Shimizu W, Tomaselli G, Tracy C, Document Reviewers, Ackerman M, Belhassen B, Estes NA 3rd, Fatkin D, Kalman J, Kaufman E, Kirchhof P, Schulze-Bahr E, Wolpert C, Vohra J, Refaat M, Etheridge SP, Campbell RM, Martin ET, Quek SC, Heart Rhythm Society; European Heart Rhythm Association, Asia Pacific Heart Rhythm Society (2013) Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Europace 15:1389–1406CrossRef Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C, Blom N, Brugada J, Chiang CE, Huikuri H, Kannankeril P, Krahn A, Leenhardt A, Moss A, Schwartz PJ, Shimizu W, Tomaselli G, Tracy C, Document Reviewers, Ackerman M, Belhassen B, Estes NA 3rd, Fatkin D, Kalman J, Kaufman E, Kirchhof P, Schulze-Bahr E, Wolpert C, Vohra J, Refaat M, Etheridge SP, Campbell RM, Martin ET, Quek SC, Heart Rhythm Society; European Heart Rhythm Association, Asia Pacific Heart Rhythm Society (2013) Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Europace 15:1389–1406CrossRef
20.
Zurück zum Zitat Patton KK, Ellinor PT, Ezekowitz M, Kowey P, Lubitz SA, Perez M, Piccini J, Turakhia M, Wang P, Viskin S, American Heart Association Electrocardiography, and Arrhythmias Committee of the Council on Clinical Cardiology, and Council on Functional Genomics, and Translational Biology (2016) Electrocardiographic early repolarization: a scientific statement from the American Heart Association. Circulation 133:1520–1529CrossRef Patton KK, Ellinor PT, Ezekowitz M, Kowey P, Lubitz SA, Perez M, Piccini J, Turakhia M, Wang P, Viskin S, American Heart Association Electrocardiography, and Arrhythmias Committee of the Council on Clinical Cardiology, and Council on Functional Genomics, and Translational Biology (2016) Electrocardiographic early repolarization: a scientific statement from the American Heart Association. Circulation 133:1520–1529CrossRef
21.
Zurück zum Zitat Hulten E, Aslam S, Osborne M, Abbasi S, Bittencourt MS, Blankstein R (2016) Cardiac sarcoidosis: state of the art review. Cardiovasc Diagn Ther 6:50–63PubMedPubMedCentral Hulten E, Aslam S, Osborne M, Abbasi S, Bittencourt MS, Blankstein R (2016) Cardiac sarcoidosis: state of the art review. Cardiovasc Diagn Ther 6:50–63PubMedPubMedCentral
24.
Zurück zum Zitat Nishi T, Takaoka H, Funabashi N, Nishimura M, Ohara O, Makiyama T, Ueda M, Kajiyama T, Kobayashi Y (2016) Familial lamin A/C mutation cardiomyopathy with arrhythmia substrate detected by cardiac magnetic resonance imaging and electroanatomical mapping. Int J Cardiol 209:248–252CrossRef Nishi T, Takaoka H, Funabashi N, Nishimura M, Ohara O, Makiyama T, Ueda M, Kajiyama T, Kobayashi Y (2016) Familial lamin A/C mutation cardiomyopathy with arrhythmia substrate detected by cardiac magnetic resonance imaging and electroanatomical mapping. Int J Cardiol 209:248–252CrossRef
25.
Zurück zum Zitat Sueda S, Kohno H, Ochi T, Uraoka T, Tsunemitsu K (2017) Overview of the pharmacological spasm provocation test: comparisons between acetylcholine and ergonovine. J Cardiol 69:57–65CrossRef Sueda S, Kohno H, Ochi T, Uraoka T, Tsunemitsu K (2017) Overview of the pharmacological spasm provocation test: comparisons between acetylcholine and ergonovine. J Cardiol 69:57–65CrossRef
26.
Zurück zum Zitat Ong P, Athanasiadis A, Hill S, Vogelsberg H, Voehringer M, Sechtem U (2008) Coronary artery spasm as a frequent cause of acute coronary syndrome: the CASPAR (Coronary Artery Spasm in Patients With Acute Coronary Syndrome) Study. J Am Coll Cardiol 52:523–527CrossRef Ong P, Athanasiadis A, Hill S, Vogelsberg H, Voehringer M, Sechtem U (2008) Coronary artery spasm as a frequent cause of acute coronary syndrome: the CASPAR (Coronary Artery Spasm in Patients With Acute Coronary Syndrome) Study. J Am Coll Cardiol 52:523–527CrossRef
27.
Zurück zum Zitat Sueda S, Kohno H (2016) Overview of complications during pharmacological spasm provocation tests. J Cardiol 68:1–6CrossRef Sueda S, Kohno H (2016) Overview of complications during pharmacological spasm provocation tests. J Cardiol 68:1–6CrossRef
28.
Zurück zum Zitat Anzai H, Momiyama Y, Kimura M (1999) Cardiac sarcoidosis complicated by multivessel coronary spasm: a case report. J Cardiol 34:85–91PubMed Anzai H, Momiyama Y, Kimura M (1999) Cardiac sarcoidosis complicated by multivessel coronary spasm: a case report. J Cardiol 34:85–91PubMed
29.
Zurück zum Zitat Matsue Y, Suzuki M, Nishizaki M, Hojo R, Hashimoto Y, Sakurada H (2012) Clinical implications of an implantable cardioverter-defibrillator in patients with vasospastic angina and lethal ventricular arrhythmia. J Am Coll Cardiol 60:908–913CrossRef Matsue Y, Suzuki M, Nishizaki M, Hojo R, Hashimoto Y, Sakurada H (2012) Clinical implications of an implantable cardioverter-defibrillator in patients with vasospastic angina and lethal ventricular arrhythmia. J Am Coll Cardiol 60:908–913CrossRef
30.
Zurück zum Zitat Ahn JM, Lee KH, Yoo SY, Cho YR, Suh J, Shin ES, Lee JH, Shin DI, Kim SH, Baek SH, Seung KB, Nam CW, Jin ES, Lee SW, Oh JH, Jang JH, Park HW, Yoon NS, Cho JG, Lee CH, Park DW, Kang SJ, Lee SW, Kim J, Kim YH, Nam KB, Lee CW, Choi KJ, Song JK, Kim YH, Park SW, Park SJ (2016) Prognosis of variant angina manifesting as aborted sudden cardiac death. J Am Coll Cardiol 68:137–145CrossRef Ahn JM, Lee KH, Yoo SY, Cho YR, Suh J, Shin ES, Lee JH, Shin DI, Kim SH, Baek SH, Seung KB, Nam CW, Jin ES, Lee SW, Oh JH, Jang JH, Park HW, Yoon NS, Cho JG, Lee CH, Park DW, Kang SJ, Lee SW, Kim J, Kim YH, Nam KB, Lee CW, Choi KJ, Song JK, Kim YH, Park SW, Park SJ (2016) Prognosis of variant angina manifesting as aborted sudden cardiac death. J Am Coll Cardiol 68:137–145CrossRef
31.
Zurück zum Zitat Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, Deal BJ, Dickfeld T, Field ME, Fonarow GC, Gillis AM, Granger CB, Hammill SC, Hlatky MA, Joglar JA, Kay GN, Matlock DD, Myerburg RJ, Page RL (2018) 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines and the Heart Rhythm Society. Heart Rhythm 15:e190–e252CrossRef Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, Deal BJ, Dickfeld T, Field ME, Fonarow GC, Gillis AM, Granger CB, Hammill SC, Hlatky MA, Joglar JA, Kay GN, Matlock DD, Myerburg RJ, Page RL (2018) 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines and the Heart Rhythm Society. Heart Rhythm 15:e190–e252CrossRef
33.
Zurück zum Zitat Fink K, Schwarz M, Feldbrügge L, Sunkomat JN, Schwab T, Bourgeois N, Olschewski M, von Zur MC, Bode C, Busch HJ (2010) Severe endothelial injury and subsequent repair in patients after successful cardiopulmonary resuscitation. Crit Care 14:R104CrossRef Fink K, Schwarz M, Feldbrügge L, Sunkomat JN, Schwab T, Bourgeois N, Olschewski M, von Zur MC, Bode C, Busch HJ (2010) Severe endothelial injury and subsequent repair in patients after successful cardiopulmonary resuscitation. Crit Care 14:R104CrossRef
34.
Zurück zum Zitat Sueda S (2020) Pharmacological spasm provocation testing in 2500 patients: provoked spasm incidence, complications and cardiac events. Heart Vessels 35:1368–1377CrossRef Sueda S (2020) Pharmacological spasm provocation testing in 2500 patients: provoked spasm incidence, complications and cardiac events. Heart Vessels 35:1368–1377CrossRef
35.
Zurück zum Zitat Sueda S, Fujimoto K, Sasaki Y, Sakaue T, Yoshii T, Habara H, Kohno H (2019) Differential incidence and morphology of provoked spasm between intracoronary acetylcholine and ergonovine testing: recommendation of supplementary use. Heart Vessels 34:745–754CrossRef Sueda S, Fujimoto K, Sasaki Y, Sakaue T, Yoshii T, Habara H, Kohno H (2019) Differential incidence and morphology of provoked spasm between intracoronary acetylcholine and ergonovine testing: recommendation of supplementary use. Heart Vessels 34:745–754CrossRef
Metadaten
Titel
Vasospastic angina and overlapping cardiac disorders in patients resuscitated from cardiac arrest
verfasst von
Kazuya Tateishi
Yuichi Saito
Hideki Kitahara
Hiroyuki Takaoka
Yusuke Kondo
Takashi Nakayama
Yoshihide Fujimoto
Yoshio Kobayashi
Publikationsdatum
29.09.2020
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 3/2021
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-020-01705-x

Weitere Artikel der Ausgabe 3/2021

Heart and Vessels 3/2021 Zur Ausgabe

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.